Search - tctmd.com

Displaying 41 - 60 of 73

Sort: Relevancy | Date

News Daily News

‘Manageable’ Stroke Risk Seen With Electrical LAA Isolation

Todd Neale

August 19, 2019

News Industry News

Adagio Medical Treats First Persistent Atrial Fibrillation Patient With One Shot+™ Cryoablation Catheter Utilizing Only Anatomical Markers For Accurate Imaging

July 31, 2019

News Conference News EuroPCR 2019

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

L.A. McKeown

June 06, 2019

News Conference News HRS 2019

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

Todd Neale

May 10, 2019

News Industry News

Biosense Webster Announces Initial Results From First In-Human Study Of Novel High Power-Short Duration Ablation Catheter For Atrial Fibrillation

May 09, 2019

News Industry News

SentreHEART Receives CE Mark for LARIAT-RS™ 50mm and Expanded Indication for Left Atrial Appendage Exclusion

May 03, 2019

News Industry News

First Atrial Fibrillation Patient Treated In Biosense Webster U.S. IDE Study Evaluating High Power, Short Duration Ablation Catheter

February 04, 2019

News Industry News

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

July 24, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Conference News HRS 2018

CABANA Misses Primary Endpoint, but Electrophysiologists See Support for Ablation

Todd Neale

May 10, 2018

News Industry News

Boston Scientific Announces Acquisition of Securus Medical Group, Inc.

April 10, 2018

News Daily News

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

L.A. McKeown

February 09, 2018

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Daily News

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Yael L. Maxwell

July 17, 2015

News Industry News

SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial

June 29, 2015

News Industry News

CardioFocus' HeartLight® U.S. Pivotal Results Presented at Late-Breaking Clinical Trial Session at Heart Rhythm 2015

May 15, 2015

News Industry News

Medtronic Receives FDA Approval and CE Mark for Arctic Front Advance® ST Cryoballoon to Treat Atrial Fibrillation

May 12, 2015

News Industry News

GOLD AF Registry to Capture Real-World Insights Using Medtronic Phased RF Ablation to Treat Patients with Atrial Fibrillation

April 07, 2015

News Industry News

Medtronic-Sponsored European Clinical Trial to Evaluate Cryoballoon Ablation as First-Line Treatment for Patients with Symptomatic Paroxysmal Atrial Fibrillation

January 07, 2015

News Daily News

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Yael L. Maxwell

August 07, 2014

Advertisement

‘Manageable’ Stroke Risk Seen With Electrical LAA Isolation

Adagio Medical Treats First Persistent Atrial Fibrillation Patient With One Shot+™ Cryoablation Catheter Utilizing Only Anatomical Markers For Accurate Imaging

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

Biosense Webster Announces Initial Results From First In-Human Study Of Novel High Power-Short Duration Ablation Catheter For Atrial Fibrillation

SentreHEART Receives CE Mark for LARIAT-RS™ 50mm and Expanded Indication for Left Atrial Appendage Exclusion

First Atrial Fibrillation Patient Treated In Biosense Webster U.S. IDE Study Evaluating High Power, Short Duration Ablation Catheter

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

CABANA Misses Primary Endpoint, but Electrophysiologists See Support for Ablation

Boston Scientific Announces Acquisition of Securus Medical Group, Inc.

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial

CardioFocus' HeartLight® U.S. Pivotal Results Presented at Late-Breaking Clinical Trial Session at Heart Rhythm 2015

Medtronic Receives FDA Approval and CE Mark for Arctic Front Advance® ST Cryoballoon to Treat Atrial Fibrillation

GOLD AF Registry to Capture Real-World Insights Using Medtronic Phased RF Ablation to Treat Patients with Atrial Fibrillation

Medtronic-Sponsored European Clinical Trial to Evaluate Cryoballoon Ablation as First-Line Treatment for Patients with Symptomatic Paroxysmal Atrial Fibrillation

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content